Achyut Healthcare Limited shareholders approved the audited financial statements for FY26 and re-appointed Jigen J. Modi as Managing Director during the company's 31st Annual General Meeting held on September 29, 2026.

The meeting, conducted entirely through video conferencing, also ratified the re-appointment of Mahendra C. Raycha as a director retiring by rotation. Additionally, members approved the re-appointment of two non-executive independent directors, Sonu Lalitkumar Jain and Rutvik Sanjaykumar Thakkar, for a five-year term effective November 1, 2026.

AGM proceedings and voting details

The Annual General Meeting commenced at 10:30 am and concluded at 10:39 am. The company reported that the Statutory Auditors' Report and Secretarial Audit Report contained no qualifications. Voting was conducted electronically via the National Securities Depository Ltd. system, with results to be disclosed on or before October 1, 2026.

Shareholder participation

The company disclosed that 21 shareholders participated in the meeting out of a total shareholder base of 3,955 as of the record date. Of the participants, seven were from the promoter and promoter group, while 14 were public shareholders. No physical meeting or proxy appointment arrangements were made, adhering to Ministry of Corporate Affairs circulars regarding virtual meetings.

Achyut Healthcare reported a significant expansion in top-line growth for FY26, with revenue from operations rising 281% year-on-year to ₹1,159.5 lakh. However, the bottom line contracted as net profit after tax fell 39% to ₹31.6 lakh, compared to ₹51.5 lakh in the previous fiscal year.

The Ahmedabad-based pharmaceutical firm submitted its 31st Annual Report on September 5, 2026, disclosing audited financials for the year ended March 31, 2026. Alongside the results, the Board of Directors approved a Scheme of Amalgamation with Zenith Healthcare Limited, subject to shareholder and regulatory approvals.

Financial Performance

The company’s total income for FY26 stood at ₹1,197.2 lakh, driven primarily by the surge in operational revenue. While revenue grew sharply, other income declined significantly from ₹92.1 lakh in FY25 to ₹37.7 lakh in FY26. This drop in non-operating income contributed to the overall compression in profitability despite higher sales volumes.

Expenses rose proportionally with revenue. Purchase of traded goods increased to ₹1,018.9 lakh from ₹300.1 lakh in FY25. Other expenses also saw a substantial jump to ₹126.1 lakh, up from ₹18.9 lakh, reflecting increased operational activity and bad debts written off amounting to ₹15.0 lakh.

What the Numbers Show

A key divergence in the financial data is the decoupling of revenue growth from profit generation. While revenue more than tripled, net profit nearly halved. This indicates that the cost structure scaled faster than sales, with gross margins likely under pressure. Furthermore, the sharp decline in other income—down 59% YoY—suggests that the previous year’s profits were partially buoyed by non-recurring or interest-based gains that did not materialize at similar levels in FY26.

Corporate Developments

The Board recommended no dividend for FY26, opting to retain profits for business growth. The company has been actively expanding its manufacturing capabilities, with capital work in progress rising to ₹2,788.5 lakh from ₹1,829.0 lakh in FY25. Commercial production from its new facilities is expected to commence in January 2026.

Additionally, Achyut Healthcare migrated its listing from the BSE SME platform to the Main Board effective January 2, 2026. The Board also approved the re-appointment of Managing Director Jigen J. Modi and two independent directors, Sonu Lalitkumar Jain and Rutvik Sanjaykumar Thakkar, for five-year terms starting November 1, 2026.